Price Alert

Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

1.08

0.14 (14.86%)

At close: Aug 15, 2025, 3:59 PM

1.05

-2.79%

After-hours: Aug 15, 2025, 07:06 PM EDT

Oncolytics Biotech Balance Sheet Statement

Financials in CAD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	15.3M	15.94M	19.6M	24.85M	27.23M	31.53M	39.98M	17.52M	15.87M	11.67M	32.36M	33.69M	39.48M	41.26M	48.09M	50.8M	50.36M
Short-Term Investments	n/a	n/a	n/a	2.56M	2.37M	3.38M	3.72M	6.83M	13.8M	20.47M	2.41M	1.72M	5.08M	1.36M	1.45M	47.94M	48.31M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	227K	227K	998K	-0.00	0.00	n/a	n/a	n/a	n/a	n/a
Receivables	89K	68K	104K	n/a	n/a	15K	630K	559K	730K	521K	496.86K	355.61K	102.22K	n/a	251.32K	135.86K	111.67K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.22M	980K	1.09M	2.42M	725K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	18.49M	18.88M	22.91M	30.63M	33.38M	38.17M	45.34M	31M	34.26M	35.68M	38.21M	39.41M	43.54M	44.9M	51.59M	55.44M	53.36M
Property-Plant & Equipment	1.22M	1.31M	1.35M	1.44M	1.37M	647K	752K	744K	840K	652K	753.71K	831.87K	910.71K	976.29K	1M	870.38K	824.88K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.22M	1.31M	1.35M	1.44M	1.37M	647K	752K	971K	1.07M	1.65M	753.71K	831.87K	910.71K	976.29K	1M	870.38K	824.88K
Total Assets	19.7M	20.19M	24.26M	32.07M	34.75M	38.82M	46.09M	31.97M	35.33M	37.33M	38.96M	40.24M	44.45M	45.88M	52.59M	56.31M	54.18M
Account Payables	779K	1.09M	3.43M	886K	744K	1.08M	2.19M	629K	528.00	2.25M	3.32K	2.18K	2.05K	594K	2.33K	2.19K	1.92K
Deferred Revenue	n/a	n/a	n/a	n/a	-744K	-1.08M	2.35M	1.74M	-528	n/a	-3.32K	-2.18K	-2.05K	-594K	-2.33K	-2.19K	-1.92K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	530K	1.62M	489K	1.26M	314K	532K	5.29M	153K	48K	79K	50.03K	31.36K	68.23K	407.84K	106.06K	153.97K	237.55K
Total Current Liabilities	5.77M	6.69M	7.66M	6.14M	4.1M	4.24M	10.02M	2.65M	2.47M	3.94M	3.67M	2.54M	2.42M	2.69M	2.71M	2.58M	2.41M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	368.00	n/a	n/a	n/a
Total Long-Term Liabilities	7.44M	7.52M	7.54M	7.62M	7.68M	7.02M	7.05M	7.08M	7.11M	6.89M	6.9M	6.92M	7.01M	7.09M	7.17M	7.24M	7.1M
Total Liabilities	13.21M	14.2M	15.21M	13.76M	11.78M	11.26M	17.07M	9.73M	9.58M	10.83M	10.56M	9.47M	9.43M	9.78M	9.88M	9.82M	9.51M
Total Debt	1M	1.06M	1.06M	1.12M	1.13M	423K	514K	479K	567K	373K	460.78K	522.44K	584.12K	654.75K	710.74K	744.51K	624.33K
Common Stock	445.53M	438.19M	434.46M	434.55M	432.51M	430.91M	428.83M	413.42M	409.41M	404.04M	398.07M	396.81M	396.5M	391.35M	391.17M	391.12M	382.96M
Retained Earnings	-484.4M	-477.71M	-469.7M	-460.15M	-452.9M	-446M	-442.05M	-432.13M	-424.69M	-418.25M	-409.7M	-405.29M	-400.19M	-393.42M	-385.66M	-380.79M	-373.55M
Comprehensive Income	958K	961K	653K	722K	670K	544K	655K	554K	659K	662K	722.63K	453.24K	340.73K	387.74K	406.45K	311.54K	359.91K
Shareholders Equity	6.49M	5.98M	9.06M	18.31M	22.97M	27.56M	29.02M	22.24M	25.75M	26.5M	28.4M	30.77M	35.02M	36.1M	42.71M	46.49M	44.67M
Total Investments	n/a	n/a	n/a	2.56M	2.37M	3.38M	3.72M	6.83M	13.8M	20.47M	2.41M	1.72M	5.08M	1.36M	1.45M	47.94M	48.31M